Syndax Pharmaceuticals SNDX Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

HTF

Heartflow, Inc. Common StockHTFL

$836K+99.5%

Jackson FinancialJXN

$14M+75.0%

Procore TechnologiesPCOR

$997K-59.3%

The BancorpTBBK

$1.05M+113%

Oruka Therapeutics, Inc.ORKA

$446K-75.2%

BancFirst CorporationBANF

$427K+676%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.77B+95.0%

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's accretion (amortization) of discounts and premiums, investments?: Syndax Pharmaceuticals (SNDX) reported accretion (amortization) of discounts and premiums, investments of $862K in Q1 2026.
How has Syndax Pharmaceuticals's accretion (amortization) of discounts and premiums, investments changed year-over-year?: Syndax Pharmaceuticals's accretion (amortization) of discounts and premiums, investments decreased by 76.0% year-over-year, from $3.6M to $862K.